Farnesi-de-Assunção, T.S.; Oliveira-Scussel, A.C.d.M.; Rodrigues, W.F.; Matos, B.S.; da Silva, D.A.A.; de Andrade e Silva, L.E.; Mundim, F.V.; Helmo, F.R.; Bernardes e Borges, A.V.; Desidério, C.S.;
et al. COVID-19 Inflammatory Syndrome: Lessons from TNFRI and CRP about the Risk of Death in Severe Disease. Biomedicines 2024, 12, 2138.
https://doi.org/10.3390/biomedicines12092138
AMA Style
Farnesi-de-Assunção TS, Oliveira-Scussel ACdM, Rodrigues WF, Matos BS, da Silva DAA, de Andrade e Silva LE, Mundim FV, Helmo FR, Bernardes e Borges AV, Desidério CS,
et al. COVID-19 Inflammatory Syndrome: Lessons from TNFRI and CRP about the Risk of Death in Severe Disease. Biomedicines. 2024; 12(9):2138.
https://doi.org/10.3390/biomedicines12092138
Chicago/Turabian Style
Farnesi-de-Assunção, ThaÃs Soares, Ana Carolina de Morais Oliveira-Scussel, Wellington Francisco Rodrigues, Beatriz Sodré Matos, Djalma Alexandre Alves da Silva, Leonardo EurÃpedes de Andrade e Silva, Fabiano Vilela Mundim, Fernanda Rodrigues Helmo, Anna Victória Bernardes e Borges, Chamberttan Souza Desidério,
and et al. 2024. "COVID-19 Inflammatory Syndrome: Lessons from TNFRI and CRP about the Risk of Death in Severe Disease" Biomedicines 12, no. 9: 2138.
https://doi.org/10.3390/biomedicines12092138
APA Style
Farnesi-de-Assunção, T. S., Oliveira-Scussel, A. C. d. M., Rodrigues, W. F., Matos, B. S., da Silva, D. A. A., de Andrade e Silva, L. E., Mundim, F. V., Helmo, F. R., Bernardes e Borges, A. V., Desidério, C. S., Trevisan, R. O., Obata, M. M. S., Barbosa, L. M., Lemes, M. R., Costa-Madeira, J. C., Barbosa, R. M., Cunha, A. C. C. H., Pereira, L. Q., Tanaka, S. C. S. V.,
... Júnior, V. R.
(2024). COVID-19 Inflammatory Syndrome: Lessons from TNFRI and CRP about the Risk of Death in Severe Disease. Biomedicines, 12(9), 2138.
https://doi.org/10.3390/biomedicines12092138
